About this trial
This study is to develop, test, and optimize a soft hip wearable robot for individuals who have experience a stroke.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
- Be at least 6 months post-stroke, have a diagnosis of Parkinson's, have a diagnosis of multiple sclerosis, or an adult older than 65 with no known neurological diagnoses.
Age: 18-89 years of age
For stroke, Parkinson's, multiple sclerosis, or older adult participants, must have adequate cognitive function (MMSE score >17)
Ability to walk at least 10 meters with maximum of 1 person assist
Disqualifiers
- <90 days post major orthopedic surgery (i.e. hip, knee, and/or ankle joint replacement.)
< 6 months post CABG or cardiac valve procedure
Any skin irritations / conditions that may preclude a participant from tolerating the use of the exosuit.
Severe osteoporosis, defined as osteoporosis that has been diagnosed and a participant's doctor has recommended pharmacologic treatment, or there is both a history of osteoporosis and a history of fractures.
Trial design
Single group
Treatments tested in this trial
WIM Robotic Exoskeleton
DeviceWearable hip-powered exoskeleton
Treatment groups
Trial outcomes
Primary outcomes
6-minute walk test
Primary outcome for Optimization aim of study.
Metabolic Cost
Primary outcome for Optimization aim of study. Data collected using Cosmed K5 Metabolic Unit
Sponsors and contacts
Click on the lead sponsor to view all of their trials.